Sign In
Buy AIM
$0.254
+0.0186 (+7.91%)
At Close: Jul 31, 2026
Poolbeg Pharma shares rise 10% as Australian patent grant bolsters POLB 001 commercial appeal
06:03am, Tuesday, 31'st Mar 2026
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF)shares rose as much as 10% in Tuesday morning trading after the AIM-listed biopharmaceutical company secured its first national patent grant for POLB
Record North Slope lease sale by supermajors shines fresh light on 88 Energy's Alaskan ambitions
11:04am, Monday, 30'th Mar 2026
ExxonMobil, ConocoPhillips, Repsol and Shell have just competed at the most successful lease sale ever held in Alaska's National Petroleum Reserve. The timing could hardly be better for 88 Energy Ltd
Spectra Systems shares rise 8% as sensor contract drives record profits
06:15am, Monday, 30'th Mar 2026
Shares in Spectra Systems Corporation (AIM:SPSY, OTC:SCTQ) rose 8% to 136p after the AIM-listed banknote authentication and security technology company reported a doubling of adjusted earnings per sha
Directa Plus slumps on warning of administration risk unless funding talks succeed
05:20am, Monday, 30'th Mar 2026
Directa Plus PLC (AIM:DCTA, OTC:DTPKF) shares fell 17.5% to 7.01p after the graphene products company warned it could be placed into administration if it fails to secure fresh funding within weeks. Th
Greatland Resources shares up strongly after it expands Telfer gold resource by 150%
05:02am, Monday, 30'th Mar 2026
Shares in Greatland Resources Ltd (AIM:GGP, OTC:GRLGF, FRA:G8G, ASX:GGP) rose 7% to 545.45p after the AIM-listed gold and copper miner reported a 150% expansion in the mineral resource at its flagshi
Mirriad shares collapse 47% as virtual advertising group warns on funding
04:18am, Monday, 30'th Mar 2026
Shares in Mirriad Advertising PLC (AIM:MIRI, FRA:8WQ, OTCQX:MMDDF) fell 47% to 0.0029p after the AIM-listed virtual product placement company warned it will need to raise further funds before publishi
88 Energy begins permitting for Alaska exploration well targeting 64m barrels
02:52am, Monday, 30'th Mar 2026
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ), the AIM and ASX-listed oil and gas explorer, has commenced permitting and planning for the Augusta-1 exploration well on Alaska's North Slope, t
Hargreaves Services launches £20 million tender offer at 16% premium
06:00am, Friday, 27'th Mar 2026
Hargreaves Services Plc (AIM:HSP, OTC:HGRVF) the AIM-listed environmental services group, saw its shares jump 8% after it launched a tender offer to return up to £20 million to shareholders at 850 pe
Seeing Machines targets positive EBITDA as GSR regulation set to drive royalty surge
03:51am, Friday, 27'th Mar 2026
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z), the AIM-listed AI-powered operator monitoring systems company, expects adjusted EBITDA to turn positive in both the third quarter and second half of
Sintana Announces Amendments to its By-Laws
07:40am, Thursday, 26'th Mar 2026
TORONTO, ON / ACCESS Newswire / March 26, 2026 / Sintana Energy Inc. (TSX-V:SEI)(AIM:SEI)(OTCQX:SEUSF) ("Sintana" or the "Company") announces that its board of directors (the "Board") has approved ame
88 Energy launches share placing to fund upcoming Alaska oil drilling
05:30am, Wednesday, 25'th Mar 2026
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) aims to raise up to the equivalent of £2.62 million (A$5.03 million) to help fund drill plans in Alaska. The AIM and ASX-listed explorer pric
Aimia Inc. (AIM:CA) Q4 2025 Earnings Call Transcript
10:44am, Tuesday, 24'th Mar 2026
Aimia Inc. (AIM:CA) Q4 2025 Earnings Call Transcript
What's Going On With AIM ImmunoTech Stock Friday?
11:07am, Friday, 20'th Mar 2026
AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments.
80 Mile shares up as it eyes more liquidity in London
09:02am, Wednesday, 18'th Mar 2026
80 Mile PLC (AIM:80M, OTCQB:BLLYF) shares jumped on Wednesday as it revealed it is moving its shares from the London Stock Exchange's SETSqx platform to SETS from today, a step the company said shoul
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors
08:36am, Wednesday, 18'th Mar 2026
AIM also intends to pursue Japanese Orphan Drug Designation for Ampligen in treatment of pancreatic cancer AIM also intends to pursue Japanese Orphan Drug Designation for Ampligen in treatment of panc
